Neuland Laboratories share news and announcements
NSE: NEULANDLABBSE: 524558Pharmaceuticals & BiotechnologySmall Cap
Last close ₹18,865.00down ₹70.00 (0.37%)BSE ₹18,924.25
Share price at the NSE close on 23 Oct 2026. Previous close ₹18,935.00.
52-week range of traded prices to 23 Oct 2026
₹11,500.00Low, 23 Mar 2026₹24,225.00High, 9 Sep 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹24,204 Cr356th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 5 Aug 2026
- 48.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 12 May 2026
- 12.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.18%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 5 Aug 2026
- 29.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 5 Aug 2026
- 32.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 12 May 2026
- 0.10
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 53,34748.3% delivered
Neuland Laboratories board meetings
108 filed, newest first. Page 3 of 3.
Jul 2010
14 Jul · Board meeting
To consider and take on record the Un-audited financial results of the Company for the quarter ended June 30, 2010.
May 2010
12 May · Board meeting
Company had informed the exchange that a meeting of the Board of Directors will be held on May 28, 2010 to consider and take on record the Annual Audited Results of the company for the year ended March 31, 2010. The Company has now informed the exchange that the meeting of the Board of Directors of the Company is scheduled to be held on May 29, 2010 to consider and take on record the Annual Audited Results of the company for the year ended March 31, 2010.Not held on this date
7 May · Board meeting
To consider and take on record the annual audited financial results of the company for the year ended March 31, 2010.
Jan 2010
12 Jan · Board meeting
Meeting on 28 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Oct 2009
6 Oct · Board meeting
Meeting on 20 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”
Jun 2009
24 Jun · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2009.
Apr 2009
9 Apr · Board meeting
To consider and take on record the audited financial results of the company for the year ended March 31, 2009. Further the Company has informed that the company is not declaring un-audited results for the quarter ended March 31, 2009.
Jan 2009
9 Jan · Board meeting
Meeting on 22 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”